Latest ZTS reports update at 2024-02-13: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. Stock Zoetis
Zoetis logo

Zoetis ZTS

$ 158.42 3.3%
mail-toReport an Error

Country

 usaUSA

IPO year

 2013

Industry

 Biotechnology

Stock Exchange

 NYSESPB

CEO

 Mr. Juan Alaix

Employees in the company

 10 600

Shares

 461 M

Market Cap[1]

 $ 73.1 B

EBITDA (LTM)

 $ 480 M

P/E (LTM)

 31.8

P/S (LTM)

 9.05

EPS (LTM)

 5.06

Zoetis is a global leader in animal health and veterinary medicine, providing a wide range of products and services to improve animal health, including medicines, vaccines, diagnostic tests, and animal health management programs. The company was created in 2013 after being spun off from Pfizer Inc., and is headquartered in New Jersey, USA.

Zoetis works with farmers, veterinarians, and other professionals in the livestock and animal health industries around the world. The company is committed to innovation and developing new products and services to improve animal health and provide more effective animal health management. Zoetis is also actively involved in social responsibility, supporting various charitable organizations and programs.

Today, Zoetis has a presence in over 100 countries and serves millions of animals. The company is constantly striving to improve its products and services to meet the needs of its customers and partners.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Pluristem Therapeutics Pluristem Therapeutics
PSTI
 		$ 1.03 -1.9 % $ 33.3 M Nasdaq Global Select Market israelIsrael
Cortexyme Cortexyme
CRTX
 		$ 1.88 -1.05 % $ 67.1 M Nasdaq Global Select Market,SPB usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
 		$ 0.27 -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
Cerus Corporation Cerus Corporation
CERS
 		$ 1.71 0.59 % $ 308 M Nasdaq Global Market usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
 		$ 0.43 -16.75 % $ 25.8 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		$ 1.47 -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		$ 4.93 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
Cue Biopharma Cue Biopharma
CUE
 		$ 1.37 -3.19 % $ 62.7 M Nasdaq Capital Market,SPB usaUSA
Advaxis Advaxis
ADXS
 		$ 0.31 -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
 		$ 11.21 0.36 % $ 1.44 B Nasdaq Capital Market usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
 		$ 3.93 -5.76 % $ 99.8 M Nasdaq Capital Market usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		$ 6.2 - $ 154 M Nasdaq Capital Market usaUSA
Zymeworks Zymeworks
ZYME
 		$ 6.42 - $ 404 M NYSE canadaCanada
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
 		$ 9.21 0.55 % $ 245 M Nasdaq Capital Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		$ 10.5 - $ 231 M Nasdaq Global Market usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
 		$ 1.44 -1.71 % $ 68.3 M NYSE American,SPB usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		$ 9.5 - $ 1.7 B Nasdaq Global Select Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		$ 3.17 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		$ 2.58 -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Zosano Pharma Corporation Zosano Pharma Corporation
ZSAN
 		$ 0.56 7.23 % $ 2.72 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.